Moreover, while circulating levels of muscle- and cardiac-enriched miRNAs have been shown to correlate to troponins after MI, differences in the release of ncRNAs and novel protein biomarkers such as cMyBP-C have not been compared in the clinically most relevant setting of MI patients presenting early with low troponin values. Here, MYBPC3 is linked to myocardial infarction.